Diabeloop Raises €70 Million in Series C
Diabeloop, a France-based medical device company that offers AI-based, personalized solutions to automate the treatment and management of diabetes, announced that it raised €70 million in its Series C round of funding.
Diabeloop, a France-based medical device company that offers AI-based, personalized solutions to automate the treatment and management of diabetes, announced that it raised €70 million in its Series C round of funding.
The round was led by LBO France, joined by Terumo Corporation, and Innovacom, and backed by Diabeloop’s historical partners.
The funds will help Diabeloop accelerate the company’s commercial roll-out and support its sustained growth strategy and its ‘high-impact’ projects.
Company: Diabeloop SA
Raised: €70.0M
Round: Series C
Funding Month: June 2022
Lead Investors: LBO France
Additional Investors: Terumo Corporation, Innovacom, and backed by Diabeloop’s historical partners
Company Website: https://www.diabeloop.com/
Software Category: AI-based Diabetes Treatment and Management
About the Company: Founded in 2015 by Erik Huneker and Guillaume Charpentier, Diabeloop is a high-growth company that offers AI-based, personalized solutions to automate the treatment and management of diabetes. The company develops machine-learning software for diabetes treatment, automating insulin delivery. Diabeloop aims to make innovation accessible to people living with diabetes, improving clinical results while relieving them of their constant mental burden. DBLG1 System, Diabeloop’s first medical device for automated insulin delivery (AID), and DBL-hu, its solution for highly unstable Type 1 diabetes management, are both CE-marked and being deployed in Europe. Diabeloop has seen impressive growth in the last few years with two products on the European market, rapidly approaching 10,000 equipped patients one year after commercial launch, and major developments with various device partners. Diabeloop’s mission is to make innovation accessible to people living with diabetes, improving clinical results while relieving them of their constant mental burden.
Source: https://www.diabeloop.com/info-press/diabeloop-therapeutic-ai-applied-to-insulin-delivery-new-financing-round https://siliconcanals.com/crowdfunding/diabeloop-secures-70m/
